In most cases, food poisoning is mild, but it can be severe and even life-threatening in some situations, especially for people with weakened immune systems, older adults, and young children

A spokesperson for Eli Lilly, which produces Zepbound and Mounjaro, told The Independent that Zepbound and Mounjaro autoinjectors and Zepbound vials are approved for single-use onlydose-splitting or microdosing is not contemplated by the FDA-label and may pose patient safety risks. Novo Nordisk, which produces Ozempic and Wegovy, told The Independent the company "[does] not condone the misuse of our products." The company noted it is concerned about non-FDA approved knock-off versions of semaglutide and sources spreading misinformation about GLP-1s to the public. The FDA warns that using unapproved versions of GLP-1 drugs can be risky for patients. This story was updated on September 4, 2025 to include responses from Eli Lilly and Novo Nordisk Join our commenting forum Join thought-provoking conversations, follow other Independent readers and see their replies Comments

A lower maintenance dose is a middle path some providers consider, without controlled-trial evidence to guide it (Aronne et al., JAMA 2024)
PMC 12216184
Click here to listen to this article Share via GLP-1 medications shift how your body handles digestion, often leading to side effects like bloating or irregularity